Sujal M. Patel - 19 Mar 2025 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Signature
/s/ Mathew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
19 Mar 2025
Net transactions value
+$76,918
Form type
4
Filing time
21 Mar 2025, 16:44:37 UTC
Previous filing
04 Mar 2025
Next filing
09 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $53,028 +53,300 +0.53% $0.9949 10,117,788 19 Mar 2025 Direct F1
transaction NAUT Common Stock Purchase $23,890 +23,933 +0.24% $0.9982 10,141,721 20 Mar 2025 Direct F2
holding NAUT Common Stock 1,814,035 19 Mar 2025 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F3
holding NAUT Common Stock 5,280,476 19 Mar 2025 By PFV I, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F4 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.